ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novel shows promise in Phase II schizophrenia trial europeanpharmaceuticalreview
February 26, 2021KarXT significantly reduced both positive and negative of symptoms of schizophrenia without the common problematic side effects of current antipsychotic therapies.
Pharma Sources Insight January 2025
